ImmunityBio (IBRX) Change in Account Payables (2014 - 2026)
ImmunityBio (IBRX) posted quarterly Change in Account Payables of $3.9 million for Q1 2026, down 39.42% year-over-year from $6.4 million in Q1 2025, and up 298.47% quarter-over-quarter from $979000.0 in Q4 2025.
Powered by 
Analysis
ImmunityBio (IBRX) Change in Account Payables (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Change in Account Payables for 13 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 39.42% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at -$2.7 million (down 161.8% YoY), while the FY2025 annual figure was -$190000.0, up 94.0% from the prior year.
- Change in Account Payables rose to $3.9 million in Q1 2026 per IBRX's latest filing, from $979000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.4 million in Q1 2025 and bottomed at -$8.9 million in Q3 2024.
- Historically, Change in Account Payables has averaged $121647.1 across 5 years, with a median of $668000.0 in 2023.
- Annual changes were most pronounced in 2023 — Change in Account Payables sank 758.35% — and 2024, when it jumped 545.81%.
- ImmunityBio's Change in Account Payables stood at $437000.0 in 2022, then tumbled by 758.35% to -$2.9 million in 2023, then retreated by 11.71% to -$3.2 million in 2024, then jumped by 130.46% to $979000.0 in 2025, then jumped by 298.47% to $3.9 million in 2026.
- Business Quant data shows IBRX's Change in Account Payables at $3.9 million in Q1 2026, $979000.0 in Q4 2025, and -$1.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | ImmunityBio | 8.45 Bn | 8.09 Bn | 50.94 Mn | -247,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -247,000.00 |
| Mar 31, 2026 | 3.90 Mn |
| Dec 31, 2025 | 979,000.00 |
| Sep 30, 2025 | -1.39 Mn |
| Jun 30, 2025 | -6.22 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | -3.21 Mn |
| Sep 30, 2024 | -8.92 Mn |
| Jun 30, 2024 | 4.66 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | -2.88 Mn |
| Sep 30, 2023 | -2.73 Mn |
| Jun 30, 2023 | -1.54 Mn |
| Mar 31, 2023 | 668,000.00 |
| Dec 31, 2022 | 437,000.00 |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 5.74 Mn |
| Mar 31, 2022 | 795,000.00 |
| Dec 31, 2021 | -3.55 Mn |
| Sep 30, 2021 | -2.77 Mn |